Skip to Content

Sera Prognostics Inc Class A SERA

Morningstar Rating
$10.75 +0.41 (3.97%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SERA is trading at a 61% discount.
Price
$9.93
Fair Value
$35.54
Uncertainty
Extreme
1-Star Price
$683.27
5-Star Price
$8.22
Economic Moat
Tvdv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SERA is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$10.34
Day Range
$10.0710.90
52-Week Range
$1.5211.32
Bid/Ask
$10.00 / $13.00
Market Cap
$350.89 Mil
Volume/Avg
59,111 / 208,208

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1,054.35
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Growth
Total Number of Employees
57

Comparables

Valuation

Metric
SERA
688468
TIHE
Price/Earnings (Normalized)
19.40
Price/Book Value
4.672.01
Price/Sales
1,054.356.00
Price/Cash Flow
15.87
Price/Earnings
SERA
688468
TIHE

Financial Strength

Metric
SERA
688468
TIHE
Quick Ratio
2.484.85
Current Ratio
2.515.74
Interest Coverage
−687.76644.72
Quick Ratio
SERA
688468
TIHE

Profitability

Metric
SERA
688468
TIHE
Return on Assets (Normalized)
−31.89%7.84%
Return on Equity (Normalized)
−38.66%9.23%
Return on Invested Capital (Normalized)
−39.45%8.57%
Return on Assets
SERA
688468
TIHE
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncFmrpmczhwYtdz$209.3 Bil
DHR
Danaher CorpMvlyxmxbjYgldnf$182.1 Bil
IQV
IQVIA Holdings IncFtypmgjmTvktq$42.8 Bil
IDXX
IDEXX Laboratories IncNgyzvwnydHrgydnp$41.5 Bil
A
Agilent Technologies IncTlpnnqknyFkfky$40.4 Bil
MTD
Mettler-Toledo International IncQqxsvxvdwPqcvyx$26.5 Bil
ICLR
Icon PLCJwkpzlzGhsmzts$24.8 Bil
ILMN
Illumina IncRzsxnqfwnJvlvkf$19.5 Bil
WAT
Waters CorpJpkpvdzzbRld$18.5 Bil
LH
Laboratory Corp of America HoldingsWbmyknvhpFmysml$16.7 Bil

Sponsor Center